Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13

• Published in: The Journal of biological chemistry Vol. 272; no. 31; pp. 19518 - 19524
• Main Authors: Nagira, Morio, Imai, Toshio, Hieshima, Kunio, Kusuda, Jun, Ridanpää, Maaret, Takagi, Shin, Nishimura, Miyuki, Kakizaki, Mayumi, Nomiyama, Hisayuki, Yoshie, Osamu
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.1997; American Society for Biochemistry and Molecular Biology
• Subjects: Amino Acid Sequence; Base Sequence; Calcium - metabolism; Cell Line; Chemokine CCL21; Chemokines, CC - genetics; Chromosome Mapping; Chromosomes, Human, Pair 9; Cloning, Molecular; Humans; Lymphocytes - immunology; Molecular Sequence Data; Recombinant Proteins - biosynthesis
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.272.31.19518

By searching the Expressed Sequence Tag (EST) data base, we identified partial cDNA sequences potentially encoding a novel human CC chemokine. We determined the entire cDNA sequence which encodes a highly basic polypeptide of 134 amino acids total with a putative signal peptide of 23 amino acids. The predicted mature protein of 111 amino acids has the four canonical cysteine residues and shows 21–33% identity to other human CC chemokines, but has a unique carboxyl-terminal extension of about 30 amino acids which contains two extra cysteine residues. The mRNA was expressed strongly in tissues such as the lymph nodes, Appendix, and spleen. The recombinant protein, which was produced by the baculovirus system and purified to homogeneity, was a highly efficient chemoattractant for certain human T cell lines and a highly potent one for freshly isolated peripheral blood lymphocytes and cultured normal T cells expanded by phytohemagglutinin and interleukin 2. Unlike most other CC chemokines, however, this novel chemokine was not chemotactic for monocytes or neutrophils, suggesting that it is specific for lymphocytes. From these results, we designated this novel CC chemokine as SLC fromsecondary lymphoid-tissuechemokine. SLC fused with the secreted form of alkaline phosphatase (SLC-SEAP) was used to characterize the SLC receptor. Binding of SLC-SEAP to freshly isolated lymphocytes was blocked by SLC (IC50, 0.12 nm) but not by any other CC chemokine so far tested, suggesting that resting lymphocytes express a class of receptors highly specific for SLC. By using somatic cell hybrids, radiation hybrids, and selected yeast and bacterial artificial chromosome clones, we mapped the SLC gene (SCYA21) at chromosome 9p13 and between chromosomal markers, D9S1978(WI-8765) and AFM326vd1, where the gene for another novel CC chemokine termed ELC from EBI1-ligandchemokine (SCYA19) also exists. Collectively, SLC is a novel CC chemokine specific for lymphocytes and, together with ELC, constitutes a new group of chemokines localized at chromosome 9p13.